BRIEF published on 11/21/2025 at 11:30, 9 months 20 days ago La délégation allemande impressionnée par les progrès rapides et l'innovation de Shenzhen Croissance Économique Technologie IA Ville Intelligente Innovation De Shenzhen Médias Allemands
BRIEF published on 11/21/2025 at 11:29, 9 months 20 days ago Franchissement de seuil chez Ubisoft Entertainment par Goldman Sachs Investissement Franchissement De Seuil Marché Boursier Goldman Sachs Ubisoft
BRIEF published on 11/21/2025 at 11:29, 9 months 20 days ago Goldman Sachs reaches a new investment threshold at Ubisoft Entertainment Investment Stock Market Goldman Sachs Threshold Crossing Ubisoft
BRIEF published on 11/21/2025 at 11:28, 9 months 20 days ago Franchissement de Seuils d'UBISOFT par Bank of America Franchissement De Seuils Bank Of America Merrill Lynch International Ubisoft Capital Et Droits De Vote
BRIEF published on 11/21/2025 at 11:28, 9 months 20 days ago Bank of America crosses thresholds for Ubisoft Crossing Thresholds Bank Of America Merrill Lynch International Ubisoft Capital And Voting Rights
BRIEF published on 11/21/2025 at 11:28, 9 months 20 days ago Franchissements de seuil chez Teleperformance par Norges Bank Droits De Vote Franchissement De Seuil Norges Bank Teleperformance Actions Collatérales
BRIEF published on 11/21/2025 at 11:28, 9 months 20 days ago Threshold crossings at Teleperformance by Norges Bank Voting Rights Threshold Crossing Norges Bank Teleperformance Collateral Actions
BRIEF published on 11/21/2025 at 11:27, 9 months 20 days ago Franchissement de Seuils chez MAAT PHARMA Droits De Vote Augmentation De Capital Franchissement De Seuils MaaT Pharma Invus Public Equities
BRIEF published on 11/21/2025 at 11:27, 9 months 20 days ago Crossing Thresholds at MAAT PHARMA Voting Rights Capital Increase Crossing Thresholds MaaT Pharma Invus Public Equities
BRIEF published on 11/21/2025 at 11:26, 9 months 20 days ago Franchissement de seuil par Sofinnova Partners dans INVENTIVA Franchissement De Seuil Bons De Souscription Inventiva Actions Et Droits De Vote Sofinnova Partners
Published on 09/11/2026 at 17:00, 2 hours 11 minutes ago Critical Elements Selected for Canada Investment Summit Prospectus, Showcasing Project to Leading Global Investors
Published on 09/11/2026 at 17:00, 2 hours 11 minutes ago Critical Elements sélectionné pour inclusion dans le prospectus du sommet Canadien de l'investissement, mettant le projet en valeur auprès d'investisseurs mondiaux de premier plan
Published on 09/11/2026 at 15:25, 3 hours 46 minutes ago Revolve Signs Agreement to Acquire 9.6 MW Operating Wind Project in the US and Secures Project-Level Debt Financing with EDC and Vancity
Published on 09/11/2026 at 15:00, 4 hours 11 minutes ago Regentis Biomaterials Reports First Half 2026 Financial Results and Provides Corporate Update
Published on 09/11/2026 at 14:30, 4 hours 41 minutes ago AIAI Holdings Enters into Extended Lock-up Agreements to Protect Long-Term Stockholder Value
Published on 09/11/2026 at 18:15, 56 minutes ago CGTN: How BRICS creates new opportunities for Global South development
Published on 09/11/2026 at 18:00, 1 hour 11 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 18:00, 1 hour 11 minutes ago ROCTOOL: INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 09/11/2026 at 07:00, 12 hours 11 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 12 hours 11 minutes ago Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 12 hours 11 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 12 hours 11 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 23 hours 41 minutes ago Availability of the 2026 Interim Financial Report
